Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Breast Neoplasms × Filgrastim × Clear all

Phase

Phase 2 31 Phase 3 12 Phase 1/2 11 Phase 1 11 Phase 4 4 Phase NA 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 13 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma 10 Lymphoma, Non-Hodgkin 9 Lymphoma, Mantle-Cell 9 Lymphoma, Large-Cell, Immunoblastic 9 Lymphoma, Follicular 9 Leukemia, Myeloid, Acute 9 Burkitt Lymphoma 9 Leukemia, Lymphocytic, Chronic, B-Cell 8 Lymphoma, B-Cell, Marginal Zone 7 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Myeloid, Accelerated Phase 7 Leukemia 7 Congenital Abnormalities 7 Myelodysplastic Syndromes 6 Multiple Myeloma 6 Blast Crisis 6 Recurrence 5 Myeloproliferative Disorders 5 Lymphoma, T-Cell, Cutaneous 5 Leukemia, Hairy Cell 5 Hodgkin Disease 5 Dendritic Cell Sarcoma, Interdigitating 5 Sezary Syndrome 4 Primary Myelofibrosis 4 Pdgfra-Associated Chronic Eosinophilic Leukemia 4 Mycosis Fungoides 4 Leukemia, Neutrophilic, Chronic 4 Leukemia, Myelomonocytic, Juvenile 4

Interventions

Exercise 92 Surveys and Questionnaires 46 Magnetic Resonance Spectroscopy 42 Acupuncture Therapy 40 Early Intervention, Educational 39 Blood Specimen Collection 37 Radiotherapy 35 Methods 35 Mammography 35 Educational Status 35 Standard of Care 34 Control Groups 30 Counseling 26 Psychiatric Rehabilitation 24 Sentinel Lymph Node Biopsy 23 Therapeutics 22 Cyclophosphamide 21 Yoga 19 Palliative Care 18 Biopsy 17 Resistance Training 16 Mastectomy, Segmental 15 Magnetic Resonance Imaging 15 High-Energy Shock Waves 15 Cognitive Behavioral Therapy 15 Interviews as Topic 13 Tamoxifen 12 Practice Guidelines as Topic 12 Paclitaxel 12 Neoadjuvant Therapy 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05296317 2026-02-19

EMEG-ECDD

Centre Georges Francois Leclerc

Phase NA Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡